ITF THERAPEUTICS| DUVYZAT Update

Похожие видео

Dyne Therapeutics DELIVER trial of DYNE-251 in Duchenne

Webinar: Community Update with ITF Therapeutics: Introducing DUVYZAT™ (givinostat) [March 2024]

WELCOME TO FUTURES 2025

FDA Decision on Sarepta's ELEVIDYS Webinar

Families fight for life-extending Muscular Dystrophy drug

9. Chromatin Remodeling and Splicing

CARTA: Human Microbiome Evolution with Christina Warinner

Катетерная абляция при фибрилляции предсердий

WEBINAR: Avidity EXPLORE44-OLE Functional Data Update

24. Attention and Awareness

Duchenne Muscular Dystrophy (DMD) Hope: New Treatment - Givinostat Explained! │PHARMACOLOGY

Multiple Myeloma 101 for 2025: Diagnosis, Prognosis, and Risk

REGENXBIO AFFINITY DUCHENNE: Trial of Investigational RGX-202 Gene Therapy

REGENXBIO June 2025 Webinar

Mastering the MMI: Strategies for Success in Medical School Interviews

Edgewise Webinar Sept., 3 2025

AU MBA webinar - January 12, 2026

Patient Forum: Understanding Scleroderma - The Essentials (2025)

NIEMCY JUŻ WRÓCILI Z GRENLANDII. SZUKAMY EUROPEJSKICH ŻOŁNIERZY NA WYSPIE

FDA Approved Gene Therapy | Duchenne Muscular Dystrophy